DK0819113T3 - Benzamider til behandling af neurodegenerative forstyrrelser - Google Patents

Benzamider til behandling af neurodegenerative forstyrrelser

Info

Publication number
DK0819113T3
DK0819113T3 DK96911550T DK96911550T DK0819113T3 DK 0819113 T3 DK0819113 T3 DK 0819113T3 DK 96911550 T DK96911550 T DK 96911550T DK 96911550 T DK96911550 T DK 96911550T DK 0819113 T3 DK0819113 T3 DK 0819113T3
Authority
DK
Denmark
Prior art keywords
benzamides
treatment
neurodegenerative disorders
neurodegenerative
disorders
Prior art date
Application number
DK96911550T
Other languages
Danish (da)
English (en)
Inventor
William David Flitter
William A Garland
Allan L Wilcox
Richard E Paylor
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0819113T3 publication Critical patent/DK0819113T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96911550T 1995-04-03 1996-04-03 Benzamider til behandling af neurodegenerative forstyrrelser DK0819113T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
PCT/US1996/004538 WO1996031462A1 (en) 1995-04-03 1996-04-03 Benzamides for neurodegenerative disorder treatment

Publications (1)

Publication Number Publication Date
DK0819113T3 true DK0819113T3 (da) 2001-10-15

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911550T DK0819113T3 (da) 1995-04-03 1996-04-03 Benzamider til behandling af neurodegenerative forstyrrelser

Country Status (38)

Country Link
EP (1) EP0819113B1 (cs)
JP (1) JP3479658B2 (cs)
KR (1) KR100429120B1 (cs)
CN (1) CN1073552C (cs)
AR (1) AR002978A1 (cs)
AT (1) ATE202552T1 (cs)
AU (1) AU721045B2 (cs)
BG (1) BG63384B1 (cs)
CA (1) CA2215166A1 (cs)
CO (1) CO4700431A1 (cs)
CZ (1) CZ295852B6 (cs)
DE (1) DE69613567T2 (cs)
DK (1) DK0819113T3 (cs)
DZ (1) DZ2012A1 (cs)
EA (1) EA002031B1 (cs)
EE (1) EE03437B1 (cs)
ES (1) ES2160240T3 (cs)
GR (1) GR3036466T3 (cs)
HR (1) HRP960156B1 (cs)
HU (1) HUP9801759A3 (cs)
IL (1) IL117629A (cs)
IS (1) IS1919B (cs)
MA (1) MA23837A1 (cs)
MX (1) MX9707596A (cs)
MY (1) MY121206A (cs)
NO (1) NO318441B1 (cs)
NZ (1) NZ306204A (cs)
PL (1) PL184121B1 (cs)
PT (1) PT819113E (cs)
RO (1) RO116190B1 (cs)
SA (1) SA96160739B1 (cs)
SI (1) SI0819113T1 (cs)
SK (1) SK282900B6 (cs)
TN (1) TNSN96051A1 (cs)
TR (1) TR199701114T1 (cs)
TW (1) TW381073B (cs)
WO (1) WO1996031462A1 (cs)
YU (1) YU21096A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332438A (en) * 1996-04-17 2001-02-23 Centaur Pharmaceuticals Inc Use of acetamido, amino or nitro substituted benzamide derivatives for treating of dementia associated with AIDS virus (HIV-1) infection
CA2308461A1 (en) 1997-10-27 1999-05-06 Kazuhito Ikeda Amide derivatives
EP1079820A1 (en) 1998-05-19 2001-03-07 Centaur Pharmaceuticals, Inc. Benzamide therapeutics for the treatment of inflammatory bowel disease
AU3985699A (en) 1998-05-19 1999-12-06 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
WO2000064430A1 (en) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Apoptosis inhibitors
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
EP2535059A4 (en) * 2010-02-10 2014-03-12 Public Univ Corp Yokohama City USE OF A MSIN3B BINDING COMPOUND FOR SPECIFIC BINDING TO THE NEURONIC RESTRICTIVE SILENCER FACTOR (NRSF)
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学(Cn) 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
HRP960156A2 (en) 1997-10-31
EA002031B1 (ru) 2001-12-24
CZ309897A3 (cs) 1998-12-16
KR19980703562A (ko) 1998-11-05
YU21096A (sh) 1999-03-04
CO4700431A1 (es) 1998-12-29
EA199700287A1 (ru) 1998-04-30
CZ295852B6 (cs) 2005-11-16
SK132597A3 (en) 1998-09-09
MA23837A1 (fr) 1996-12-31
AR002978A1 (es) 1998-05-27
JP3479658B2 (ja) 2003-12-15
MX9707596A (es) 1998-06-30
JPH11501319A (ja) 1999-02-02
EE03437B1 (et) 2001-06-15
TNSN96051A1 (fr) 2005-03-15
HK1016964A1 (en) 1999-11-12
GR3036466T3 (en) 2001-11-30
PL184121B1 (pl) 2002-09-30
NO318441B1 (no) 2005-03-21
EP0819113B1 (en) 2001-06-27
SK282900B6 (sk) 2003-01-09
IL117629A0 (en) 1996-07-23
EP0819113A1 (en) 1998-01-21
NO974569D0 (no) 1997-10-02
MY121206A (en) 2006-01-28
HUP9801759A3 (en) 2001-06-28
SA96160739B1 (ar) 2005-10-15
ATE202552T1 (de) 2001-07-15
WO1996031462A1 (en) 1996-10-10
TW381073B (en) 2000-02-01
SI0819113T1 (en) 2001-10-31
IS4569A (is) 1997-09-25
CN1182416A (zh) 1998-05-20
IL117629A (en) 2000-08-13
HUP9801759A2 (hu) 1998-12-28
DZ2012A1 (fr) 2002-07-21
EE9700235A (et) 1998-04-15
ES2160240T3 (es) 2001-11-01
DE69613567D1 (de) 2001-08-02
NO974569L (no) 1997-11-21
TR199701114T1 (xx) 1998-02-21
PT819113E (pt) 2001-10-30
BG101929A (en) 1998-04-30
BG63384B1 (bg) 2001-12-29
CN1073552C (zh) 2001-10-24
CA2215166A1 (en) 1996-10-10
PL322625A1 (en) 1998-02-02
KR100429120B1 (ko) 2004-08-18
DE69613567T2 (de) 2002-04-18
HRP960156B1 (en) 2002-04-30
NZ306204A (en) 1999-01-28
IS1919B (is) 2004-03-15
AU721045B2 (en) 2000-06-22
AU5440496A (en) 1996-10-23
RO116190B1 (ro) 2000-11-30

Similar Documents

Publication Publication Date Title
DK0841946T4 (da) Metoder til behandling af allergisk astma
DK0861081T3 (da) Anvendelse af epinastin til behandling af smerter
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
DK0830864T3 (da) Kombinationsbehandling til behandling af psykoser
DK0769947T3 (da) Indolinonforbindelser til behandling af sygdom
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0777457T3 (da) Anvendelse af glyceryltriacetat til behandling af onychomykoser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
DK0765854T3 (da) Fremgangsmåde til rensning af rektifikationskolonne
DK0819113T3 (da) Benzamider til behandling af neurodegenerative forstyrrelser
FI942400L (fi) Lääkeaine hermosairauksia vastaan
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
FI953747A0 (fi) Steroideja vaihdevuosivaivojen hoitoon
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis